Xinjian Liu, Fang Li, Elizabeth A Stubblefield, Barbara Blanchard, Toni L Richards, Gaynor A Larson, Yujun He, Qian Huang, Aik-Choon Tan, Dabing Zhang, Timothy A Benke, John R Sladek, Nancy R Zahniser and Chuan-Yuan Li. "Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells". Cell Research  

Tcheung WJ, Marcello JE, Puri PK, Abernethy AP, Nelson KC. Evaluation of 39 cases of pediatric cutaneous head and neck melanoma. J Am Acad Dermatol. 2010 Nov 12. [Epub ahead of print]

Raymond AK, Puri PK, Selim MA, Tyler DS, Nelson KC.Regional squamous cell carcinomas following systemic sorafenib therapy and isolated limb infusion for regionally advanced metastatic melanoma of the limb. Arch Dermatol. 2010 Dec;146(12):1438-9.

Lacouture M, Maitland M, Segaert S, Baran R, Fox L, Epstein J, Barasch A, Einhorn L, Wagner L, West D, Rapoport B, Kris M, Basch E, Eaby B, Kurtin S, Olsen EA, Dancey J, Trotti A: A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC Skin Toxicity Study Group. Support Care Cancer; 18(4): 509-22, 2010.

Anderson KA, Bartell HL, Olsen EA. Leukonychia related to vorinostat. Arch Dermatol; 145(11): 1338-9, 2009.

Duvic M, Olsen EA, Breneman D, Pacheo T, Parker S, Vonderheid E, Abuav R, Ricker J, Rizvi S, Cong C, Boileau K, Gunchenko A, Sanz-Rodriquez C, Geskin L.: Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma (CTCL). Clin Lymphoma Myeloma; 9(6): 412-6, 2009. 

Ke H, Harris RH, Jin Y, Leshin B, Miliani de Marval P, Tao S and Zhang JY. The C-Jun N-terminal kinase 2 (JNK2) displays a dominant role in human epidermal neoplasia. Cancer Res. 70(8): 3080 - 3088, 2010. A cellular signaling pathway is identified as potential therapeutic target for skin cancer.

Miliani de Marval PL, Lutfeali SA, Jin Y, Leshin B, Selim MA and Zhang JY. CYLD control epidermal tumor growth and metastasis through JNK/AP1. (Cancer Prevention Research, Mar, 2011)

Jin Y, Ke H, Hall RP and Zhang JY. JunB and c-Jun display opposite effects on epidermal growth and neoplasia. (J. of Investigative Dermatology, Feb, 2011).

Walker, Linda C, Ju, Elizabeth M; Yeowell, Heather N. Mutational analysis of 12 patienter with the phenotype of Ehlers-Danlos syndrome type VIB shows no linkage to the zinc transporter gene SLC39A13.

Seth P., Yeowell HN. Fox-2 protein regulates the alternative splicing of scleroderma-associated lysyl hydroxylase 2 massenger RNA. Arthritis Rheum. 2010 Apr:624(4):1167 - 75

Seth P., Walker LC., Yeowell HN. Identification of exonic cis-elements regulating the alternative splicing of scleroderma-associated lysyl hydroxylase 2 mRNA. In Press, J. Invest. Dermatol., 2010.

Yeowell HN., Walker LC., Mauger DM., Seth P., Garcia-Blanco MA. TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2.J.Invest. Dermtol. 2009 Jun;129(6):1402-11. Epub 2008 Dec 25.